Cardiology Devices - Sudan

  • Sudan
  • The Cardiology Devices market market in Sudan is anticipated to achieve a revenue of US$5.71m by 2024.
  • It is projected to display a compound annual growth rate (CAGR 2024-2029) of 2.08%, leading to a market volume of US$6.33m by 2029.
  • In terms of global comparison, the United States is expected to generate the highest revenue of US$25,770.00m in 2024.
  • In Sudan, there is a growing demand for advanced cardiology devices to cater to the rising prevalence of cardiovascular diseases in the country.

Key regions: United Kingdom, United States, France, Spain, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in Sudan is experiencing steady growth due to increasing customer preferences for advanced medical technologies and the rising incidence of cardiovascular diseases in the country. Customer preferences in Sudan are shifting towards advanced cardiology devices that offer improved accuracy, efficiency, and patient comfort. Patients and healthcare providers are increasingly opting for minimally invasive procedures and non-surgical treatments, leading to a higher demand for devices such as cardiac catheters, stents, and implantable cardioverter-defibrillators (ICDs). This preference for less invasive procedures is driven by the desire to minimize patient discomfort, reduce recovery time, and lower healthcare costs. Additionally, there is a growing awareness among patients about the benefits of early detection and treatment of cardiovascular diseases, which is driving the demand for diagnostic devices such as electrocardiography (ECG) machines and echocardiography systems. The market is also witnessing a trend towards the integration of digital technology in cardiology devices. This includes the use of telemedicine solutions, remote monitoring devices, and mobile applications that allow healthcare providers to remotely monitor patients' heart health and provide timely interventions. This trend is particularly beneficial in Sudan, where there is a shortage of specialized healthcare professionals and limited access to quality healthcare services in remote areas. The integration of digital technology in cardiology devices enables better disease management, reduces the need for frequent hospital visits, and improves patient outcomes. Local special circumstances in Sudan, such as a high prevalence of risk factors for cardiovascular diseases, including hypertension, diabetes, and obesity, are contributing to the growth of the Cardiology Devices market. The country's population is also aging, leading to an increased demand for cardiac interventions and treatments. Additionally, Sudan has witnessed an improvement in healthcare infrastructure and an increase in healthcare spending, which has further fueled the demand for cardiology devices. Underlying macroeconomic factors, such as Sudan's economic growth and increasing disposable income levels, are also driving the growth of the Cardiology Devices market. As the country's economy continues to develop, more individuals are able to afford advanced medical treatments and procedures, including cardiology interventions. Furthermore, the government's focus on improving healthcare services and infrastructure is creating a favorable environment for the growth of the market. In conclusion, the Cardiology Devices market in Sudan is experiencing steady growth due to increasing customer preferences for advanced medical technologies, the rising incidence of cardiovascular diseases, and the integration of digital technology in cardiology devices. Local special circumstances, such as a high prevalence of risk factors and an aging population, along with underlying macroeconomic factors, including economic growth and increasing disposable income levels, are further driving the market's growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)